|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
79
|
Sun, 8/2/09, 4:00 PM - 5:50 PM | CC-201 |
| Multiple Trials, Multiple Comparison, and Multiple Endpoints - Contributed - Papers | ||
|
Biopharmaceutical Section |
||
| Chair(s): Tammy Massie , FDA | ||
| 4:05 PM |
Comparison of Multiple Testing Methods in a Trial with Co-Primary Endpoints —  Moumita Sinha, Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
| 4:20 PM |
Combining Multiple Tests in Clinical Trials with Hierarchical Objectives — Alexei A. Dmitrienko, Eli Lilly and Company; Ajit C. Tamhane, Northwestern University; Lingyun Liu, Northwestern University
|
|
| 4:35 PM |
Simultaneous Critical Values for t-Tests in Very High Dimensions — Hongyuan Cao, The University of North Carolina at Chapel Hill; Michael Kosorok, The University of North Carolina at Chapel Hill
|
|
| 4:50 PM |
Evaluating Multiple Endpoints in Two Pivotal Trials — Brian L. Wiens, Gilead Sciences, Inc.; Alexei A. Dmitrienko, Eli Lilly and Company
|
|
| 5:05 PM |
An Efficient Algorithm to Determine the Optimal Two-Stage Randomized Multinomial Designs in Oncology Clinical Trials — Yong Zhang, University of Michigan; William L. Mietlowski, Novartis Oncology; Bee Chen, Novartis Oncology; Yibin Wang, Novartis Oncology
|
|
| 5:20 PM |
Overall Power for Testing Co-Primary Hypothesis with Multiple Endpoints — Fang Liu, Merck Research Laboratories
|
|
| 5:35 PM |
Extended Fallback Procedures with Clinical Trial Applications — Yan D. Zhao, Eli Lilly and Company; Alexei A. Dmitrienko, Eli Lilly and Company; Brian L. Wiens, Gilead Sciences, Inc.
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |